William B. Downs

发表

A Method of Showing and Shipping Orthodontic Models

William B. Downs, 2009 .

Analysis of the Dentofacial Profile

William B. Downs, W. Downs, 2009 .

Hypothesizing Nutrigenomic-Based Precision Anti-Obesity Treatment and Prophylaxis: Should We Be Targeting Sarcopenia Induced Brain Dysfunction?

William B. Downs, K. Blum, P. Thanos, 2021, International journal of environmental research and public health.

Hypothesizing repetitive paraphilia behavior of a medication refractive Tourette's syndrome patient having rapid clinical attenuation with KB220Z-nutrigenomic amino-acid therapy (NAAT).

William B. Downs, Margaret A. Madigan, K. Blum, 2013, Journal of behavioral addictions.

Neurogenetics and Clinical Evidence for the Putative Activation of the Brain Reward Circuitry by a Neuroadaptagen: Proposing an Addiction Candidate Gene Panel Map

William B. Downs, Thomas J. H. Chen, K. Blum, 2011, Journal of psychoactive drugs.

Genospirituality: Our Beliefs, Our Genomes, and Addictions

William B. Downs, K. Blum, M. Oscar-Berman, 2013, Journal of addiction research & therapy.

Early Intervention of Intravenous KB220IV- Neuroadaptagen Amino-Acid Therapy (NAAT)™ Improves Behavioral Outcomes in a Residential Addiction Treatment Program: A Pilot Study

William B. Downs, Margaret A. Madigan, Thomas J. H. Chen, 2012, Journal of psychoactive drugs.

Hypodopaminergia and "Precision Behavioral Management" (PBM): It is a Generational Family Affair.

William B. Downs, K. Blum, P. Thanos, 2019, Current pharmaceutical biotechnology.

Withdrawal from Buprenorphine/Naloxone and Maintenance with a Natural Dopaminergic Agonist: A Cautionary Note.

William B. Downs, K. Blum, D. Barh, 2013, Journal of addiction research & therapy.

Neurogenetics and Nutrigenomics of Neuro-Nutrient Therapy for Reward Deficiency Syndrome (RDS): Clinical Ramifications as a Function of Molecular Neurobiological Mechanisms.

William B. Downs, K. Blum, D. Barh, 2012, Journal of addiction research & therapy.

UNDERSTANDING THE HIGH MIND: HUMANS ARE STILL EVOLVING GENETICALLY

William B. Downs, Margaret A. Madigan, K. Blum, 2011 .

Reward Deficiency Syndrome (RDS): A Cytoarchitectural Common Neurobiological Trait of All Addictions

William B. Downs, K. Blum, J. Cadet, 2021, International journal of environmental research and public health.

Hypothesizing that Marijuana Smokers are at a Significantly Lower Risk of Carcinogenicity Relative to Tobacco-Non-Marijuana Smokers: Evidenced Based on Statistical Reevaluation of Current Literature

William B. Downs, Thomas J. H. Chen, K. Blum, 2008, Journal of psychoactive drugs.

A short term pilot open label study to evaluate efficacy and safety of LG 839 , a customized DNA directed nutraceutical in obesity : Exploring Nutrigenomics Research

William B. Downs, Thomas J. H. Chen, K. Blum, 2009 .

A short term pilot open label study to evaluate efficacy and safety of LG839, a customized DNA directed nutraceutical in obesity: Exploring Nutrigenomics

William B. Downs, Thomas J. H. Chen, K. Blum, 2008 .

Addiction by Any Other Name is Still Addiction: Embracing Molecular Neurogenetic/Epigenetic Basis of Reward Deficiency

William B. Downs, K. Blum, P. Thanos, 2020, Journal of addiction science.